Vestibo Tablet

Betahistine Dihydrochloride
8mg
National Healthcare Pvt. Ltd.
Pack size 100'st
Dispensing mode
Source
Agent
Retail Price 6.00 NPR

Available as:

Indications

Vestibo Tablet is used for: Meniere's disease, tinnitus and/or progressive loss of hearing, vertigo, dizziness.

Adult Dose

Adult: Initially, 8-16 mg tid. Maintenance: 24-48 mg daily.

Child Dose

Renal Dose

Administration

Should be taken with food.

Contra Indications

Phaeochromocytoma. Porphyria.

Precautions

Active peptic ulcer, bronchial asthma, pregnancy and lactation.

Pregnancy-Lactation

Interactions

May antagonise antihistamines. May decrease bronchodilator effects of beta-2 agonists.

Adverse Effects

Side effects of Betahistine Dihydrochloride : Rash, pruritus, urticaria, dyspepsia, nausea, peptic ulcer disease, headache, dizziness, insomnia.

Mechanism of Action

Betahistine improves the microcirculation in the labyrinth which reduces endolymphatic pressure.

Note

Vestibo 8mg Tablet manufactured by National Healthcare Pvt. Ltd.. Its generic name is Betahistine Dihydrochloride. Vestibo is availble in Nepal. Farmaco Nepal drug index information on Vestibo Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Betahistine Dihydrochloride :